Clinical Trial Update: Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial for stem cell therapy aimed at treating lung injury caused by major infectious diseases; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: Cell Energy Life Sciences Group Co. LTD | Conditions: Lung Injury | Phase 1, Phase 2 | Status: RECRUITING